Related Experiment Video

Updated: Apr 2, 2026

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.7K

Predictive Biomarkers for Immune Checkpoint Inhibitor Therapy in Advanced Melanomas

Emma Wagner1, Banafshé Larijani2, Amanda Robinson Kirane1

  • 1Division of General Surgery, Department of Surgery, Section of Surgical Oncology, Stanford University School of Medicine, 1201 Welch Road, Stanford, CA 94305, USA.

Surgical Oncology Clinics of North America
|May 24, 2025
PubMed
Abstract

Keywords:
BiomarkerImmune checkpointImmunotherapyMelanomaPredictiveQuantitativeSpatial

More Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

6.0K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

15.7K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K